News Sentiment

NEU sentiment intelligence

Neuren Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 21 relevant articles
Exchange ASX Australia
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 16.52 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

87/100 classification confidence.

Company focus 21

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-1.3% over one week, +23.4% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Growth Investors: Industry Analysts Just Upgraded Their Neuren Pharmaceuticals Limited (ASX:NEU) Revenue Forecasts By 55%

Market Reaction

Balanced read

65/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 87/100 classification
One-week reaction -1.3% Price digesting
Trend fit Trend inactive 23.4% over four weeks
Fair value 4.2% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 5
Neutral 15
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 21
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
simplywall.st 6
Kalkine 6
Market source 4
The Motley Fool Australia 3
Kalkine Media 1
thebull.com.au 1

Event Lens

What the news is about

Classified themes
Market update 16
Earnings 4
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-21 of 21